HIGHLIGHTS
- who: Pierre Gaudeaux from the (IRCCS), Italy University of Birmingham have published the article: T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation, in the Journal: (JOURNAL)
- how: This culture process can be applied to all sources of HSC (such as umbilical cord blood and blood of mobilized donors) .
SUMMARY
Allogeneic hematopoietic stem_cell transplantation (allo-HSCT) is the only available cure for many hematopoietic malignancies and several non-malignant conditions. Before giving rise to fully mature CD4+ or CD8+ singlepositive T_cells (SPs), thymocytes undergo . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.